Michael Bär

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +11

Perifosine Plus Bortezomib and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma Previously Treated With Bortezomib: Results of a Multicenter Phase I/II Trial

Paul G. Richardson, J. Wolf, Andrzej Jakubowiak et al. · Journal of Clinical Oncology · 2011 · 119 citations · Full text

Perifosine Plus Bortezomib, Hematological Malignancy, Relapsed/refractory Mm +13

Disseminated Pneumocystis carinii infection in a patient with acquired immunodeficiency syndrome

Margaret M. Grimes, Jonathan D. LaPook, Michael Bär et al. · Human Pathology · 1987 · 112 citations

Primary Immunodeficiency, Medicine, Pneumocystis Carinii Infection +2

Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment

David S. Siegel, Gary J. Schiller, Christy Samaras et al. · Leukemia · 2020 · 77 citations · Full text

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

Ziad Bakouny, Chris Labaki, Punita Grover et al. · JAMA Oncology · 2022 · 62 citations · Full text